[go: up one dir, main page]

WO2000005369A3 - Sequences nucleotidiques et sequences d'acides amines de proteines secretees en rapport avec l'angiogenese - Google Patents

Sequences nucleotidiques et sequences d'acides amines de proteines secretees en rapport avec l'angiogenese Download PDF

Info

Publication number
WO2000005369A3
WO2000005369A3 PCT/US1999/012839 US9912839W WO0005369A3 WO 2000005369 A3 WO2000005369 A3 WO 2000005369A3 US 9912839 W US9912839 W US 9912839W WO 0005369 A3 WO0005369 A3 WO 0005369A3
Authority
WO
WIPO (PCT)
Prior art keywords
angiogenesis
secreted proteins
amino acid
proteins involved
acid sequences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1999/012839
Other languages
English (en)
Other versions
WO2000005369A2 (fr
Inventor
Richard A Shimkets
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CuraGen Corp
Original Assignee
CuraGen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CuraGen Corp filed Critical CuraGen Corp
Priority to JP2000561315A priority Critical patent/JP2002522019A/ja
Priority to AU50818/99A priority patent/AU5081899A/en
Priority to CA002335326A priority patent/CA2335326A1/fr
Priority to EP99935312A priority patent/EP1098974A2/fr
Publication of WO2000005369A2 publication Critical patent/WO2000005369A2/fr
Publication of WO2000005369A3 publication Critical patent/WO2000005369A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/515—Angiogenesic factors; Angiogenin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Cette invention concerne de nouvelles protéines angiogéniques/anti-angiogéniques sécrétées et les séquences d'acides aminés codant pour ces protéines.
PCT/US1999/012839 1998-07-20 1999-07-20 Sequences nucleotidiques et sequences d'acides amines de proteines secretees en rapport avec l'angiogenese Ceased WO2000005369A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2000561315A JP2002522019A (ja) 1998-07-20 1999-07-20 新脈管形成に関与する分泌タンパク質のヌクレオチド配列およびアミノ酸配列
AU50818/99A AU5081899A (en) 1998-07-20 1999-07-20 Nucleotide sequences and amino acid sequences of secreted proteins involved in angiogenesis
CA002335326A CA2335326A1 (fr) 1998-07-20 1999-07-20 Sequences nucleotidiques et sequences d'acides amines de proteines secretees en rapport avec l'angiogenese
EP99935312A EP1098974A2 (fr) 1998-07-20 1999-07-20 Sequences nucleotidiques et sequences d'acides amines de proteines secretees en rapport avec l'angiogenese

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US9339798P 1998-07-20 1998-07-20
US60/093,397 1998-07-20
US15068498A 1998-09-10 1998-09-10
US09/150,684 1998-09-10

Publications (2)

Publication Number Publication Date
WO2000005369A2 WO2000005369A2 (fr) 2000-02-03
WO2000005369A3 true WO2000005369A3 (fr) 2000-06-15

Family

ID=26787485

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/012839 Ceased WO2000005369A2 (fr) 1998-07-20 1999-07-20 Sequences nucleotidiques et sequences d'acides amines de proteines secretees en rapport avec l'angiogenese

Country Status (5)

Country Link
EP (1) EP1098974A2 (fr)
JP (1) JP2002522019A (fr)
AU (1) AU5081899A (fr)
CA (1) CA2335326A1 (fr)
WO (1) WO2000005369A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050043234A1 (en) 1996-10-16 2005-02-24 Deisher Theresa A. Novel FGF homologs
US20030224991A1 (en) * 2002-03-11 2003-12-04 Mohanraj Dhanabal Nucleotide sequences and amino acid sequences of secreted proteins involved in angiogenesis
AU2003279835B2 (en) 2002-10-07 2009-09-10 Zymogenetics, Inc. Methods of administering FGF18
JP2012084561A (ja) * 2010-10-06 2012-04-26 Fujitsu Semiconductor Ltd 半導体装置およびその製造方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998016644A1 (fr) * 1996-10-16 1998-04-23 Zymogenetics, Inc. Homologues de facteur de croissance fibroblastes (fgf)
WO1999015653A2 (fr) * 1997-09-19 1999-04-01 Genentech, Inc. Homologues du ligand 'tie'
WO1999040193A1 (fr) * 1998-02-04 1999-08-12 Zymogenetics, Inc. Zapo3 homologue d'angiopoietine, adn le codant et sa methode de production

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1132844B (it) 1980-09-15 1986-07-09 Nuovo Pignone Spa Perfezionamenti nelle pinze passatrama per telai tessili
EP0123005B1 (fr) 1983-04-18 1986-09-17 Maschinenfabrik Sulzer-Rüti Ag Pince pour l'insertion du fil de trame dans un métier à tisser à pince

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998016644A1 (fr) * 1996-10-16 1998-04-23 Zymogenetics, Inc. Homologues de facteur de croissance fibroblastes (fgf)
WO1999015653A2 (fr) * 1997-09-19 1999-04-01 Genentech, Inc. Homologues du ligand 'tie'
WO1999040193A1 (fr) * 1998-02-04 1999-08-12 Zymogenetics, Inc. Zapo3 homologue d'angiopoietine, adn le codant et sa methode de production

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
BECK L JR AND D'AMORE P A: "Vascular development: cellular and molecular regulation", FASEB JOURNAL,US,FED. OF AMERICAN SOC. FOR EXPERIMENTAL BIOLOGY, BETHESDA, MD, vol. 11, no. 11, pages 365-373-373, XP002102631, ISSN: 0892-6638 *
DATABASE EMBL 1 May 1997 (1997-05-01), PRÖLS F. ET AL.: "rat microvascular endotelial differentiation gene 1 (MDG1)", XP002133852 *
DATABASE GENBANK 21 June 1999 (1999-06-21), YE M. ET AL.: "Homo sapiens MDG1", XP002133853 *
DAVIS S ET AL: "Isolation of Angiopoietin-1, a ligand for Tie2 receptor, by secretion-trap expression cloning", CELL,US,CELL PRESS, CAMBRIDGE, NA, vol. 87, no. 87, pages 1161-1169-1167, XP002102730, ISSN: 0092-8674 *
KIM I. ET AL.: "Molecular cloning and characterization of a novel angiopoietin family protein, angiopoietin-3", FEBS LETTERS, vol. 443, 29 January 1999 (1999-01-29), pages 353 - 356, XP002126378 *
MAISONPIERRE P C ET AL: "ANGIOPOIETIN-2, A NATURAL ANTAGONIST FOR TIE2 THAT DISRUPTS IN VIVO ANGIOGENESIS", SCIENCE,US,AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, vol. 277, pages 55-60, XP002046280, ISSN: 0036-8075 *
OHBAYASHI N. ET AL.: "Structure and function of the mRNA encoding a novel fibroblast growth factor, FGF-18.", J. BIOL. CHEM., vol. 273, no. 29, 17 July 1998 (1998-07-17), pages 18161 - 18164, XP002133851 *
PRÖLS F. ET AL.: "Assignment of themicrovascular endothelial differentiation gene 1 (MDG1) to human chromosome band 14q24.2->q24.3 by fluorescence in situ hybridization.", CYTOGENET. CELL GENET., vol. 79, 1997, pages 149 - 150, XP002133850 *

Also Published As

Publication number Publication date
CA2335326A1 (fr) 2000-02-03
JP2002522019A (ja) 2002-07-23
AU5081899A (en) 2000-02-14
EP1098974A2 (fr) 2001-05-16
WO2000005369A2 (fr) 2000-02-03

Similar Documents

Publication Publication Date Title
WO2002014358A3 (fr) Nouvelles proteines secretees et leurs utilisations
WO2001079465A3 (fr) Acides nucleiques codant pour des polypeptides presentant une activite haloperoxydase
WO2001053312A8 (fr) Nouveaux acides nucleiques et polypeptides
WO2001053455A3 (fr) Nouveaux acides nucleiques et polypeptides associes
WO2001079462A3 (fr) Acides nucleiques codant pour des polypeptides presentant une activite haloperoxydase
WO1998056927A3 (fr) Acides nucleiques codant des polypeptides a fonction protease
WO2003054152A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2001057188A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2001057190A3 (fr) Acides nucleiques et polypeptides
WO2001066689A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2001029222A3 (fr) Polypeptides ayant une activite phospholipase b et acides nucleiques codant ces derniers
WO2003029271A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2003025154A3 (fr) Procedes et compositions pour la construction et l'utilisation de genotheques de fusion
WO1995006735A3 (fr) Sequences nucleotidiques servant a coder de nouvelles tyrosine-phosphatases proteiques
WO2001046260A3 (fr) Nouveaux membres de la superfamille des immunoglobulines apex-1, apex-2 et apex-3 et leurs utilisations
WO2003080795A3 (fr) Nouveaux acides nucléiques et polypeptides sécrétés
WO1997027276A3 (fr) Acides nucleiques codant des polypeptides presentant l'activite de la lipase d'absidia
WO2000005369A3 (fr) Sequences nucleotidiques et sequences d'acides amines de proteines secretees en rapport avec l'angiogenese
WO2003078648A3 (fr) Sequences de nucleotides et sequences d'acides amines de proteines secretees impliquees dans l'angiogenese
WO2000041509A3 (fr) Polypeptides possedant une activite de phosphatase acide et acides nucleiques codant pour ceux-ci
WO2001053453A3 (fr) Nouveaux acides nucleiques de moelle osseuse et polypeptides associes
WO2003025142A3 (fr) Nouveaux acides nucleiques et polypeptides secretes
WO2002002771A3 (fr) Nouveau gene hsparc-11 et procedes de fabrication et d'utilisation de ce dernier
WO2000046391A3 (fr) Genes affichant une expression amelioree pendant une senescence cellulaire et une differentiation cellulaire terminale, et leurs utilisations
WO2001083552A3 (fr) Acides nucleiques et polypeptides sez6 humains

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

ENP Entry into the national phase

Ref document number: 2335326

Country of ref document: CA

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2000 561315

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1999935312

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 50818/99

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 09744184

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 1999935312

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1999935312

Country of ref document: EP